Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Precigenetics is revolutionizing drug discovery by providing real-time epigenetic insights for precision medicine and targeted therapies. Its proprietary COMPASS platform offers non-destructive,…

Precigenetics is revolutionizing drug discovery by providing real-time epigenetic insights for precision medicine and targeted therapies. Its proprietary COMPASS platform offers non-destructive,…
Stage: Pre-seed / early stage
Headquarters: Philadelphia, Pennsylvania, United States
Core product: COMPASS — real-time, non-destructive single-cell epigenetic analysis platform
Founder / CEO: Parmita Mishra
Known investors: 1517 Fund; O'Shaughnessy Ventures
Precision medicine and targeted therapies, with a focus on precision oncology and accelerating drug discovery via single-cell epigenetic analysis.
2024
Biotechnology
Investors reported: 1517 Fund; O'Shaughnessy Ventures
“1517 Fund; O'Shaughnessy Ventures”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week